FindTrial
Sign In

MSI status in gallbladder cancer

Prevalence of MMR status in gallbladder cancer (GBC) treated with palliative intent and its correlation with response to chemotherapy and survival - MMR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/07/014799
Enrollment
400
Registered
2018-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who are in the age group of 18 to 70 years with histologically proven Gall baldder cancers (GBC) treated with palliative chemotherapy will be included

Exclusion criteria

Exclusion criteria: -Patients who have histology other than adenocarcinoma -Biopsy sample not sufficient for MMR testing

Design outcomes

Primary

MeasureTime frame
To determine the prevelance of MMR status by IHCin GBC treated with palliative intentTimepoint: 48 months—

Secondary

MeasureTime frame
-To correlate the MMR status with response to chemotherapy -To correlate the MMR status with survival outcomes Timepoint: 48 months—

Countries

India

Contacts

Public ContactDr Vikas sureshchand Ostwal

Tata Memorial Hospital

dr.vikas.ostwal@gmail.com9702288801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026